Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Recruiting 2Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2Thoracic 1

Conditions

Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 4Prostatic Neoplasms 3Small Cell Lung Carcinoma 2Sarcoma, Ewing 2Rectal Neoplasms 2Pulmonary Disease, Chronic Obstructive 2Melanoma 2Lymphoma, Non-Hodgkin 2Head and Neck Neoplasms 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Tuberculosis 1Thoracic Cancer 1Shwachman-Diamond Syndrome 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Recurrence 1Precancerous Conditions 1Pneumonia 1Pathologic Complete Response 1Pancreatic Intraductal Neoplasms 1Osteosarcoma 1Osteoporosis 1Neurofibrosarcoma 1Neurofibromatosis 1 1

Interventions

Ipilimumab 114pembrolizumab 94Nivolumab 91aldesleukin 86Interleukin-2 57Cyclophosphamide 54Dacarbazine 52Vemurafenib 39trametinib 37Temozolomide 37incomplete Freund's adjuvant 35fludarabine phosphate 35sargramostim 32dabrafenib 32fludarabine 26Bevacizumab 26Paclitaxel 22MART-1 Antigen 21Granulocyte-Macrophage Colony-Stimulating Factor 21montanide ISA 51 20Interferon-alpha 20Cisplatin 20Carboplatin 19Sorafenib 18Introns 17Biopsy 17cobimetinib 16Radiosurgery 16atezolizumab 15Radiotherapy 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Melanoma × X-Rays × Clear all
NCT02760225 2024-05-03

Pembrolizumab-PET Imaging

University Medical Center Groningen

Phase NA Completed
18 enrolled
DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT01295931 2015-10-07

Nuclear and Near-Infrared (NIR) Imaging in Melanoma

M.D. Anderson Cancer Center

Phase 1 Completed
20 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡